Scinai Immunotherapeutics Ltd. American Depositary Shares
Symbol: SCNI (NASDAQ)
Company Description:
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
- Today's Open: $1.28
- Today's High: $1.4
- Today's Low: $1.27
- Today's Volume: 159.70K
- Yesterday Close: $1.265
- Yesterday High: $1.28
- Yesterday Low: $1.2101
- Yesterday Volume: 51.51K
- Last Min Volume: 76
- Last Min High: $1.365
- Last Min Low: $1.362
- Last Min VWAP: $1.362
- Name: Scinai Immunotherapeutics Ltd. American Depositary Shares
- Website: https://www.scinai.com
- Listed Date: 2015-05-12
- Location: JERUSALEM, L3
- Market Status: Active
- CIK Number: 0001611747
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $3.99M
- Round Lot: 100
- Outstanding Shares: 3.15M
- Asset Type: ADRC
Filing Date | Filing Type | Format |
---|---|---|
2025-09-30 | EFFECT | View |
2025-09-22 | F-1 | View |
2025-09-22 | 6-K | View |
2025-09-11 | 6-K | View |
2025-09-08 | EFFECT | View |
2025-09-04 | POS AM | View |
2025-09-02 | 6-K | View |
2025-06-12 | 6-K | View |
2025-06-05 | 424B3 | View |
2025-06-05 | 6-K | View |
2025-06-02 | 6-K | View |
2025-05-15 | EFFECT | View |
2025-05-12 | POS AM | View |
2025-05-07 | 20-F | View |
2025-04-29 | NT 20-F | View |
2025-03-27 | 6-K | View |
2025-03-26 | SCHEDULE 13G | View |
2025-03-24 | 6-K | View |
2025-03-13 | 424B3 | View |
2025-03-12 | EFFECT | View |